These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 34523710)
1. [CYP2D6 and CYP2C19 genotyping: effectivity in psychiatric practice]. Koopmans AB; Vinkers DJ; Hoek HW; van Harten PN Tijdschr Psychiatr; 2021; 63(7):570-577. PubMed ID: 34523710 [TBL] [Abstract][Full Text] [Related]
2. No Effect of Dose Adjustment to the Koopmans AB; Vinkers DJ; Poulina IT; Gelan PJA; van Schaik RHN; Hoek HW; van Harten PN Front Psychiatry; 2018; 9():349. PubMed ID: 30131727 [No Abstract] [Full Text] [Related]
3. CYP2D6 and CYP2C19 genotyping in psychiatric patients on psychotropic medication in the former Dutch Antilles. Koopmans AB; Vinkers DJ; Gelan PJ; Hoek HW; van Harten PN Pharmacogenomics; 2017 Jul; 18(10):1003-1012. PubMed ID: 28639468 [TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19. Koopmans AB; Braakman MH; Vinkers DJ; Hoek HW; van Harten PN Transl Psychiatry; 2021 Feb; 11(1):141. PubMed ID: 33627619 [TBL] [Abstract][Full Text] [Related]
5. CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort. Ivanov HY; Grigorova D; Lauschke VM; Velinov B; Stoychev K; Kyosovska G; Shopov P J Pers Med; 2022 Jul; 12(7):. PubMed ID: 35887684 [TBL] [Abstract][Full Text] [Related]
6. Frequencies of Scherf-Clavel M; Weber H; Unterecker S; Müller DJ; Deckert J World J Biol Psychiatry; 2024 Apr; 25(4):214-221. PubMed ID: 38493365 [TBL] [Abstract][Full Text] [Related]
7. Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation. Ragia G; Pallikarou M; Manolopoulou Y; Vorvolakos T; Manolopoulos VG Pharmacogenomics; 2024; 25(5-6):217-229. PubMed ID: 38884939 [TBL] [Abstract][Full Text] [Related]
8. DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping. de Leon J; Susce MT; Johnson M; Hardin M; Maw L; Shao A; Allen AC; Chiafari FA; Hillman G; Nikoloff DM CNS Spectr; 2009 Jan; 14(1):19-34. PubMed ID: 19169185 [TBL] [Abstract][Full Text] [Related]
9. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. de Leon J; Susce MT; Murray-Carmichael E Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600 [TBL] [Abstract][Full Text] [Related]
10. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population. Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905 [TBL] [Abstract][Full Text] [Related]
11. Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis. Milosavljevic F; Bukvic N; Pavlovic Z; Miljevic C; Pešic V; Molden E; Ingelman-Sundberg M; Leucht S; Jukic MM JAMA Psychiatry; 2021 Mar; 78(3):270-280. PubMed ID: 33237321 [TBL] [Abstract][Full Text] [Related]
12. The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O-Desmethylvenlafaxine Concentrations in a Large Patient Cohort. Kringen MK; Bråten LS; Haslemo T; Molden E J Clin Psychopharmacol; 2020; 40(2):137-144. PubMed ID: 32134850 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups. Luo HR; Aloumanis V; Lin KM; Gurwitz D; Wan YJ Am J Pharmacogenomics; 2004; 4(6):395-401. PubMed ID: 15651900 [TBL] [Abstract][Full Text] [Related]
14. Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic. Müller DJ; Kekin I; Kao AC; Brandl EJ Int Rev Psychiatry; 2013 Oct; 25(5):554-71. PubMed ID: 24151801 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputation. Li D; Pain O; Fabbri C; Wong WLE; Lo CWH; Ripke S; Cattaneo A; Souery D; Dernovsek MZ; Henigsberg N; Hauser J; Lewis G; Mors O; Perroud N; Rietschel M; Uher R; Maier W; Baune BT; Biernacka JM; Bondolfi G; Domschke K; Kato M; Liu YL; Serretti A; Tsai SJ; Weinshilboum R; ; ; McIntosh AM; Lewis CM medRxiv; 2023 Dec; ():. PubMed ID: 37425775 [TBL] [Abstract][Full Text] [Related]
16. Clinical applications of CYP genotyping in psychiatry. Spina E; de Leon J J Neural Transm (Vienna); 2015 Jan; 122(1):5-28. PubMed ID: 25200585 [TBL] [Abstract][Full Text] [Related]
17. Correlation of genotype, phenotype, and mRNA expression of CYP2D6 and CYP2C19 in peripheral blood leukocytes (PBLs). Kuhlmann JB; Wensing G; Kuhlmann J Int J Clin Pharmacol Ther; 2014 Feb; 52(2):143-50. PubMed ID: 24361088 [TBL] [Abstract][Full Text] [Related]
18. Effect of Routine Cytochrome P450 2D6 and 2C19 Genotyping on Antipsychotic Drug Persistence in Patients With Schizophrenia: A Randomized Clinical Trial. Jürgens G; Andersen SE; Rasmussen HB; Werge T; Jensen HD; Kaas-Hansen BS; Nordentoft M JAMA Netw Open; 2020 Dec; 3(12):e2027909. PubMed ID: 33284338 [TBL] [Abstract][Full Text] [Related]